Overview

Vasoactive Peptides in Portal Pressure

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is looking at the detection of vasoactive peptides in portal hypertension.
Phase:
N/A
Details
Lead Sponsor:
Bayside Health
Treatments:
Norfloxacin